Page last updated: 2024-11-01

nimodipine and Cirrhosis

nimodipine has been researched along with Cirrhosis in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research Excerpts

ExcerptRelevanceReference
" We now conclude that chronic administration of nimodipine delays the formation of microvascular deposits up to the age of 30 months."1.28Formation of cerebrovascular anomalies in the ageing rat is delayed by chronic nimodipine application. ( de Jong, GI; Luiten, PG; Traber, J, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Jong, GI1
Traber, J1
Luiten, PG1

Other Studies

1 other study available for nimodipine and Cirrhosis

ArticleYear
Formation of cerebrovascular anomalies in the ageing rat is delayed by chronic nimodipine application.
    Mechanisms of ageing and development, 1992, Jul-15, Volume: 64, Issue:3

    Topics: Aging; Animals; Basement Membrane; Blood Pressure; Brain; Fibrosis; Male; Microcirculation; Microsco

1992